Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    2 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The previous Revision: v3.4.1 notice and the government funding lapse notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:14:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, warning that information may not be up to date and transactions may not be processed (with links to cc.nih.gov and opm.gov). Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:28.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include showing the glossary toggle, capitalization/style changes for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:53.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no visible changes to core study details in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:33:18.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations section updated to add Arizona, New York, Pennsylvania, and Utah sites and remove prior location blocks. The revision is labeled v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:24:57.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.